Location History:
- Suwon, KR (2009)
- Gyeonggi-Do, KR (2009)
Company Filing History:
Years Active: 2009
Title: Sun-Ahe Lee: Innovator in Cancer Treatment
Introduction
Sun-Ahe Lee is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various types of cancer. With a total of two patents to his name, Lee's work is focused on innovative solutions for serious health issues.
Latest Patents
Lee's latest patents include the N-phenyl-2-pyrimidine-amine derivatives and the process for their preparation. These compounds demonstrate superior effects on a range of cancers, including lung cancer, gastric cancer, colon cancer, pancreatic cancer, hepatoma, prostatic cancer, breast cancer, chronic or acute leukemia, hematologic malignancy, encephalophyma, bladder cancer, rectal cancer, cervical cancer, and lymphoma in warm-blooded animals. The patents also detail a pharmaceutical composition that incorporates these compounds as active ingredients, combined with pharmaceutically acceptable inert carriers.
Career Highlights
Sun-Ahe Lee is currently associated with Il-Yang Pharm. Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, contributing to the creation of effective treatment options.
Collaborations
Lee collaborates with esteemed colleagues, including Dong-Yeon Kim and Dae-Jin Cho, to further enhance the impact of his research. Their combined expertise fosters innovation and drives the development of new therapeutic solutions.
Conclusion
Sun-Ahe Lee's contributions to cancer treatment through his innovative patents highlight the importance of research in pharmaceuticals. His work not only addresses critical health challenges but also paves the way for future advancements in medical science.